- Home
- GDYN vs ORIC Comparison
GDYN vs ORIC Comparison
Compare GDYN & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDYN
- ORIC
- Stock Information
- Founded
- GDYN 2006
- ORIC 2014
- Country
- GDYN United States
- ORIC United States
- Employees
- GDYN N/A
- ORIC N/A
- Industry
- GDYN Computer Software: Prepackaged Software
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- GDYN Technology
- ORIC Health Care
- Exchange
- GDYN Nasdaq
- ORIC Nasdaq
- Market Cap
- GDYN 884.4M
- ORIC 940.8M
- IPO Year
- GDYN N/A
- ORIC 2020
- Fundamental
- Price
- GDYN $7.81
- ORIC $9.18
- Analyst Decision
- GDYN Strong Buy
- ORIC Strong Buy
- Analyst Count
- GDYN 4
- ORIC 9
- Target Price
- GDYN $17.50
- ORIC $18.29
- AVG Volume (30 Days)
- GDYN 1.2M
- ORIC 1.2M
- Earning Date
- GDYN 07-31-2025
- ORIC 08-19-2025
- Dividend Yield
- GDYN N/A
- ORIC N/A
- EPS Growth
- GDYN N/A
- ORIC N/A
- EPS
- GDYN 0.19
- ORIC N/A
- Revenue
- GDYN $389,227,000.00
- ORIC N/A
- Revenue This Year
- GDYN $21.15
- ORIC N/A
- Revenue Next Year
- GDYN $13.96
- ORIC N/A
- P/E Ratio
- GDYN $41.68
- ORIC N/A
- Revenue Growth
- GDYN 22.27
- ORIC N/A
- 52 Week Low
- GDYN $7.53
- ORIC $3.90
- 52 Week High
- GDYN $25.50
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- GDYN 21.11
- ORIC 38.66
- Support Level
- GDYN $7.75
- ORIC $9.47
- Resistance Level
- GDYN $8.35
- ORIC $10.31
- Average True Range (ATR)
- GDYN 0.47
- ORIC 0.60
- MACD
- GDYN -0.18
- ORIC -0.25
- Stochastic Oscillator
- GDYN 9.53
- ORIC 3.44
About GDYN Grid Dynamics Holdings Inc.
Grid Dynamics Holdings Inc is a provider of technology consulting, platform and product engineering, and advanced analytics services. The company delivers tailored solutions in several industry verticals like Tech, Media and Telecom, Retail, Finance and Consumer Packaged goods (CPG)/manufacturing. The company derives maximum revenue from Retails. Geographically company earns revenue from North America, Europe and other regions.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.